0
Signin
countryflagUS

18889881171

MSFT 425.025 -0.9035% AAPL 220.43 0.8648% NVDA 115.85 1.4004% GOOGL 172.44 -0.1101% GOOG 174.27 -0.0573% AMZN 182.99 1.1945% META 460.09 -0.2558% AVGO 152.64 0.859% TSLA 224.8499 4.102% TSM 161.61 1.1327% LLY 823.56 -4.2238% V 257.56 1.3338% JPM 209.535 0.453% UNH 562.83 0.5502% NVO 129.31 -1.7401% WMT 70.206 -0.5581% LVMUY 143.15 0.9022% XOM 116.85 1.5999% LVMHF 714.04 0.4982% MA 436.96 1.0429%

Akanda Corp

Healthcare US AKAN

1.6207USD
0.01(0.66%)

Last update at 2024-07-25T16:46:00Z

Day Range

1.501.63
LowHigh

52 Week Range

2.3342.00
LowHigh

Fundamentals

  • Previous Close 1.61
  • Market Cap6.75M
  • Volume108186
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-5.76764M
  • Revenue TTM2.16M
  • Revenue Per Share TTM0.48
  • Gross Profit TTM 3.27M
  • Diluted EPS TTM-245.29

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax -8.23545M -8.13120M -2.30057M -1.39464M
Minority interest - - - -
Net income 0.40M -9.22413M -2.94597M -1.88845M
Selling general administrative 19.85M 5.81M 1.36M 0.70M
Selling and marketing expenses - - - -
Gross profit 3.27M -0.71473M 0.00025M 0.00000M
Reconciled depreciation 3.76M 0.31M 0.25M 0.20M
Ebit -20.17639M -6.83373M -1.66583M -0.90124M
Ebitda -16.41152M -6.49790M -1.40654M -0.70201M
Depreciation and amortization 3.76M 0.34M 0.26M 0.20M
Non operating income net other - - - -
Operating income -20.17639M -6.83373M -1.66583M -0.90124M
Other operating expenses 22.80M 6.88M 1.67M 0.90M
Interest expense 0.12M 1.09M 0.65M 0.49M
Tax provision - - - -
Interest income 0.00089M 0.03M 0.01M 0.00040M
Net interest income -0.11444M -1.06613M -0.63497M -1.59341M
Extraordinary items - - - -
Non recurring - - - -
Other items - - - -
Income tax expense -8.63249M 1.09M 0.65M 0.49M
Total revenue 2.62M 0.04M 0.00206M 0.00000M
Total operating expenses 23.45M 6.12M 1.67M 0.90M
Cost of revenue -0.64988M 0.76M 0.00181M 0.00000M
Total other income expense net 11.94M -1.29747M -0.63474M -0.49341M
Discontinued operations -3.42223M -3.42223M -3.42223M -3.42223M
Net income from continuing ops -8.23545M -8.13120M -2.30057M -2.49464M
Net income applicable to common shares -11.65767M -8.13120M -2.30057M -1.39464M
Preferred stock and other adjustments - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 8.84M 39.00M 8.05M 4.27M -
Intangible assets 3.80M 22.21M 0.26M 0.32M -
Earning assets - - - - -
Other current assets 0.14M 0.81M 484886.00M 0.11M -
Total liab 12.67M 12.10M 10.25M 9.31M -
Total stockholder equity -3.82889M 26.90M -2.20142M -5.03194M -
Deferred long term liab - - - - -
Other current liab 2.66M 1.06M 8268428.00M - -
Common stock 51.02M 49.43M 7.26M 0.00164M -
Capital stock 51.02M 49.43M 7.26M 0.00164M -
Retained earnings -53.36303M -21.08796M -13.29389M -5.16269M -
Other liab - - - - -
Good will - - - - -
Other assets - 0.48M - - -
Cash 0.09M 0.23M 3.50M 0.01M -
Cash and equivalents - - - - -
Total current liabilities 10.17M 9.35M 8.27M 2.73M -
Current deferred revenue - - -8268428.00000M - -
Net debt 3.90M 3.67M 6.07M 9.11M -
Short term debt 1.50M 1.15M 7.59M 2.55M -
Short long term debt 1.37M 0.94M 7.15M 2.26M -
Short long term debt total 4.00M 3.90M 9.57M 9.12M -
Other stockholder equity - -1.44657M 11092467.00M 0.13M -
Property plant equipment - 12.48M 3.81M 3.83M -
Total current assets 1.81M 3.82M 3.98M 0.13M -
Long term investments - - - - -
Net tangible assets - 4.69M -2.46052M -5.35335M -
Short term investments 0.00000M 0.26M - - -
Net receivables 0.28M 1.24M 0.24M 0.00000M -
Long term debt 2.50M 2.63M - 3.98M -
Inventory 1.29M 1.06M -484885.75747M 0.00061M -
Accounts payable 6.01M 7.14M 0.68M 0.18M -
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -1.48598M -1.44657M 3.84M 0.13M -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.59M 0.48M - - -
Deferred long term asset charges - - - - -
Non current assets total 7.03M 35.18M 4.07M 4.15M -
Capital lease obligations 0.14M 0.33M 2.42M 2.88M -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -4.21866M -0.57647M -0.43220M -0.69277M
Change to liabilities 2.92M 0.00000M 0.14M 0.04M
Total cashflows from investing activities -4.21866M -0.57647M -0.43220M -0.69277M
Net borrowings -0.79444M 6.18M 1.03M 2.12M
Total cash from financing activities 14.14M 11.24M 1.03M 2.12M
Change to operating activities -0.64310M 0.37M -0.10984M 0.02M
Net income -11.65767M -8.13120M -2.30057M -1.39464M
Change in cash -3.23959M 3.48M -0.80606M 0.80M
Begin period cash flow 3.50M 0.01M 0.82M 0.02M
End period cash flow 0.26M 3.50M 0.01M 0.82M
Total cash from operating activities -11.46940M -6.55706M -1.35247M -0.64233M
Issuance of capital stock 14.93M 5.05M 0.00148M 0.00000M
Depreciation 3.76M 0.31M 0.25M 0.20M
Other cashflows from investing activities -0.73995M -0.73995M 0.00693M -0.00685M
Dividends paid - - - -
Change to inventory 0.50M -0.71252M -0.00061M -0.00061M
Change to account receivables -0.59107M -0.24236M -0.24236M -0.24236M
Sale purchase of stock - - - -
Other cashflows from financing activities 0.50M 6.68M 1.17M -0.69277M
Change to netincome -5.75785M 1.85M 0.67M 0.49M
Capital expenditures 0.31M 0.58M 0.44M 0.69M
Change receivables - - - -
Cash flows other operating - - - -
Exchange rate changes - - - -
Cash and cash equivalents changes - - - -
Change in working capital 2.18M -0.58750M 0.03M 0.06M
Stock based compensation 0.56M - - -
Other non cash items -6.31707M 1.85M 0.67M 0.49M
Free cash flow -11.78034M -7.13353M -1.79160M -1.32825M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AKAN
Akanda Corp		 0.01 0.66% 1.62 - - 0.47 0.09 1.60 -0.5888
ZTS
Zoetis Inc		 5.84 3.25% 185.50 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 -0.06 0.18% 33.64 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 -1.18 0.73% 160.95 21.73 14.95 3.16 2.15 3.56 12.82
TAK
Takeda Pharmaceutical Co Ltd ADR		 0.14 0.99% 13.71 32.67 11.53 0.01 0.87 0.02 0.07

Reports Covered

Stock Research & News

View All

Profile

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.

Akanda Corp

1a, 1b Learoyd Road, New Romney, United Kingdom, TN28 8XU

Key Executives

Name Title Year Born
Ms. Louisa Madiako Mojela B.Com., B.Comm Exec. Chairman 1956
Mr. Tejinder Virk CEO & Director 1982
Mr. Trevor W. Scott BAcc, BCom (Hons), CA(SA) CFO & Sec. 1980
Mr. Thomas Flow Chief Operating Officer 1977
Ms. Katharyn Field Interim CEO & Executive Director 1984
Dr. Gurcharn Deol B.A., M.A., Ph.D. Chief Financial Officer 1950
Mr. Thomas Flow Chief Operating Officer 1978

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.